Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-25-000340
Filing Date
2025-06-24
Accepted
2025-06-24 18:08:11
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4030
  Complete submission text file 0000904454-25-000340.txt   5494
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNIQUIRE N.V. 113 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Springhorn Jeremy P. (Reporting) CIK: 0001717852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 251070400